CIRCADIAN FLUCTUATIONS OF TISSUE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGENS IN VASOSPASTIC ANGINA

被引:38
|
作者
SAKATA, K
HOSHINO, T
YOSHIDA, H
ONO, N
OHTANI, S
YOKOYAMA, S
MORI, N
KABURAGI, T
KURATA, C
URANO, T
TAKADA, Y
TAKADA, A
机构
[1] HAMAMATSU UNIV SCH MED, DEPT INTERNAL MED 3, HAMAMATSU, SHIZUOKA 43131, JAPAN
[2] HAMAMATSU UNIV SCH MED, DEPT PHYSIOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
关键词
D O I
10.1016/0002-8703(92)90964-W
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To elucidate the circadian variation of fibrinolytic components in vasospastic angina, plasma levels of tissue plasminogen activator antigen (t-PA), free plasminogen activator inhibitor antigen (free PAI-1), t-PA/PAI-1 complex, and total PAI-1 were measured in venous plasma samples. Samples were taken every 6 hours (6:00 AM, noon, 6:00 PM, and midnight) for 24 hours in 14 patients with vasospastic angina, in 9 patients with exertional angina, and in 19 normal subjects. Twenty-four-hour Holter monitoring (Holter monitor, Del Mar Avionics, Irvine, Calif.) was also carried out in all subjects. All of the fibrinolytic components showed circadian variation, with a peak level at 6:00 AM in every study group except for the t-PA/PAI-1 complex in the group of patients with exertional angina. The values for all of the fibrinolytic components at each sampling time were higher in patients with coronary artery disease than in normal subjects. In particular, the mean value of free PAI-1 at 6:00 AM in patients with vasospastic angina was significantly higher than that in normal subjects and that in patients with exertional angina. This value of free PAI-1 in patients with vasospastic angina was closely associated with the duration of ischemic attacks. These results suggested that the circadian fluctuation of fibrinolytic components may be an important factor that leads to coronary thrombosis at the time of coronary spasm, especially in the early morning.
引用
收藏
页码:854 / 860
页数:7
相关论文
共 50 条
  • [41] INITIATION OF A FIBRINOLYTIC SYSTEM IN HEPATIC RESECTION - THE ROLES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    SHIMADA, M
    MATSUMATA, T
    YAMAMOTO, K
    ITASAKA, H
    TAKETOMI, A
    SUGIMACHI, K
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1994, 24 (09): : 780 - 784
  • [42] THE INHIBITION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 - THE EFFECTS OF FIBRINOGEN, HEPARIN, VITRONECTIN, AND LIPOPROTEIN(A)
    EDELBERG, JM
    REILLY, CF
    PIZZO, SV
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (12) : 7488 - 7493
  • [43] DETERMINANTS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY IN TREATED NIDDM AND ITS RELATION TO A POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE
    PANAHLOO, A
    MOHAMEDALI, V
    LANE, A
    GREEN, F
    HUMPHRIES, SE
    YUDKIN, JS
    DIABETES, 1995, 44 (01) : 37 - 42
  • [44] STUDIES OF RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN RABBITS - PHARMACOKINETICS AND EVIDENCE FOR REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    CIRCULATION RESEARCH, 1990, 67 (05) : 1281 - 1286
  • [45] INDEPENDENT REGULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-2 AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN HUMAN SYNOVIAL FIBROBLASTS
    HAMILTON, JA
    CHEUNG, D
    FILONZI, EL
    PICCOLI, DS
    WOJTA, J
    GALLICHIO, M
    MCGRATH, K
    LAST, K
    ARTHRITIS AND RHEUMATISM, 1992, 35 (12): : 1526 - 1534
  • [46] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITIES AS PREDICTORS OF ADVERSE EVENTS IN UNSTABLE ANGINA
    WIECZOREK, I
    LUDLAM, CA
    FOX, KAA
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (05): : 424 - 429
  • [47] EFFECT OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ON TISSUE-TYPE PLASMINOGEN ACTIVATOR-INDUCED FIBRINOLYSIS
    CARR, ME
    KRISHNAMURTI, C
    ALVING, BM
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (01) : 106 - 110
  • [48] PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITIES IN A REFERENCE POPULATION
    KRISHNAMURTI, C
    TANG, DB
    BARR, CF
    ALVING, BM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 89 (06) : 747 - 752
  • [49] PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY AND TISSUE PLASMINOGEN-ACTIVATOR LEVELS IN PATIENTS WITH UNSTABLE ANGINA AND THOSE WITH CORONARY SPASTIC ANGINA
    MASUDA, T
    YASUE, H
    OGAWA, H
    MISUMI, I
    SAKAMOTO, T
    OKUBO, H
    MIYAO, Y
    KATO, H
    AMERICAN HEART JOURNAL, 1992, 124 (02) : 314 - 319
  • [50] INTERACTIONS BETWEEN THE FINGER AND KRINGLE-2 DOMAINS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    KANEKO, M
    SAKATA, Y
    MATSUDA, M
    MIMURO, J
    JOURNAL OF BIOCHEMISTRY, 1992, 111 (02): : 244 - 248